aussss

Australia calls for investigation into China’s coronavirus response

April 29, 2020
Research and Development Australia, COVID-19, China, coronavirus

Scott Morrison, the Australian Prime Minister, has called for an investigation into the origins of the COVID-19 coronavirus, as Australia …

covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

April 29, 2020
Research and Development BARDA, COVID-19, coronavirus, hydroxychloroquine

Hydroxychloroquine continues to feature in coronavirus news. Rick Bright, the Director of BARDA, alleges he was pushed out of his …

novartis_outside_1

EU approval for Novartis’ Cosentyx in active non-radiographic axial spondyloarthritis

April 29, 2020
Research and Development, Sales and Marketing Cosentyx, EU, Novartis, axial spondyloarthritis, pharma

Novartis has revealed that the European Commission has moved to approve Cosentyx (secukinumab) for the treatment of active non-radiographic axial …

Nearly half of Americans believe COVID-19 was created in a lab, according to a new survey

April 28, 2020
Manufacturing and Production COVID-19, coronavirus, survey

Almost half of Americans believe that the coronavirus was created in a lab, according to an April survey of 6,300 …

janssen_latest_logo_on_sign_closer

NICE backtracks to approve Janssen’s Stelara in ulcerative colitis

April 28, 2020
Manufacturing and Production, Research and Development Janssen, NICE, Stelara, ulcerative colitis

NICE has recommended Janssen’s Stelara (ustekinumab) for the treatment of moderately to severely active ulcerative colitis (UC), a move which …

korean

South Korean researchers start testing pancreatitis drug in COVID-19 patients

April 28, 2020
Manufacturing and Production COVID-19, Pancreas, Pancreatitis, coronavirus

The South Korean Ministry of Food and Drug Safety have approved a local trial to evaluate nafamostat’s effectiveness in COVID-19 …

children_with_mask

12 British children hospitalised with rare condition linked to COVID-19

April 28, 2020
Manufacturing and Production COVID-19, NHS, NHS UK, coronavirus

12 children have fallen ill across the UK with a new and potentially fatal combination of symptoms linked to COVID-19. …

Reinventing the value equation

April 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, feature, real world data, real world evidence, real-world data, real-world evidence

There is a duty to ensure access to innovative treatments for patients with unmet need, but a health service gatekeeper …

Sanofi’s Meningococcal Conjugate Vaccine secures FDA approval in patients aged two and up

April 27, 2020
Sales and Marketing FDA, MenQuadfi, Sanofi, US, meningococcal disease, pharma

Sanofi’s MedQuadfi Meningococcal Conjugate Vaccine has scored FDA approval for the prevention of invasive meningococcal disease, becoming the first and …

italy_lockdown

Italy to relax COVID-19 lockdown in early May

April 27, 2020
Sales and Marketing COVID-19, COVID-19 coronavirus, Italy, coronavirus

Italy has outlined its plans to ease the lockdown restrictions that were implemented across the country 7 weeks ago to …

researchers

Researchers studying heartburn drug as potential coronavirus treatment

April 27, 2020
Sales and Marketing COVID-19, Pepcid, coronavirus, pandemic

Researchers in America have been studying famotidine, the active ingredient in Pepcid, as a potential treatment for COVID-19. Pepcid is …

hazmat

‘Excess deaths’ in England among the highest in Europe

April 27, 2020
Sales and Marketing COVID-19, coronavirus, deaths, pandemic

English excess deaths from the coronavirus are comparable to the worst hit countries in Europe, according to a Sky News …

images_1

FDA urges close monitoring of COVID-19 patients treated with hydroxychloroquine

April 27, 2020
Sales and Marketing COVID-19, FDA, chloroquine, coronavirus, hydroxychloroquine

The FDA has released a safety communication reiterating the need for doctors to closely monitor COVID-19 patients who are treated …

aloe-vera-2417091_960_720

European Medicines Agency’s review of Picato finds its risks outweigh its benefits

April 24, 2020
Business Services, Medical Communications, Sales and Marketing

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the risks from using Picato are too high …

gilead-sciences

Leading COVID-19 hope remdesivir fails to provide clinical benefit in first randomised trial

April 24, 2020
Medical Communications, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead’s remdesivir, which has been hailed as one of the few truly promising treatments for COVID-19 at this early stage …

top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

April 24, 2020
Medical Communications COVID-19, coronavirus, top 10

Hydroxychloroquine is once again a main feature in the news as it fails a coronavirus clinical trial in France, while …

wuhan

European countries wary about confronting China over COVID-19 death figures

April 24, 2020
Medical Communications COVID-19, China, coronavirus

National security experts in the UK and US believe China is underreporting the true amount of COVID-19 deaths, but European …

new_trump

Trump widely criticised for suggesting patients could receive injections of disinfectant as COVID-19 cure

April 24, 2020
Medical Communications COVID-19, coronavirus

President Donald Trump stunned the medical community by suggesting disinfectant and UV light could be used to treat patients suffering …

social_distancing

Socially disruptive measures will exist in Britain until at least the end of the year

April 23, 2020
Business Services Britian COVID-19, COVID-19, coronavirus

England’s Chief Medical Officer Chris Whitty has said that the UK will have to live with some form of socially …

The Gateway to Local Adoption Series

Latest content